Claire-Marie Coste-Lepoutre
Analyst · Versicherungsmonitor
Thank you very much, Oliver. And good morning as well from my side to all of you. So indeed, as mentioned already by Oliver, when it comes to the numbers on the first half, we had an excellent first half overall, and we delivered our highest level of operating profit to the half year. And this is supported by all segments across insurance and asset management. Our performance from my perspective, continue to demonstrate our focus on the execution of the Capital Market Day levers and also provide confidence to our ability to deliver our 2026 target. And you will see because this is a midpoint as well of our full cycle when it comes to the delivery of our Capital Market Day ambition. So moving to Slide B3, where we are, I think, already now our total business volume emerged at EUR 99 billion for the half year. We are up 4.3% with growth higher in the second quarter versus the first quarter. So clearly, we see a momentum of growth building. And actually also in the second quarter, some parts of our segments are delivering extremely well with, as an example, Asset Management with a 19% growth in the second quarter as an example. Our operating profit is at EUR 9.4 billion, which is up 9% versus last year. And here as well, all segments are contributing to that performance and in particular, P&C and Asset Management. Our shareholder net income, as mentioned already by Oliver, is impacted by various effects, which are pretty complex to reconcile if you look at it because we had divestment in the second quarter of last year. We had a divestment in the first quarter of this year. And then we have the restructuring effects, which are coming in addition. So for me, what is very important is to look at the adjusted numbers for those effects. And what you see if you do a year-on-year comparison is that our shareholder core net income is up 9%, which is excellent. And also our core EPS is up 10%, which is also excellent and ahead of our target range of 7% to 9% -- our resilience is very good at 225%. And as mentioned by Oliver, this is our highest level of solvency ratio since year-end 2018. So we have a lot of capital flexibility, which also, from my perspective, supports very well the recently announced M&A. So an excellent first half overall, and let me go into more details on the P&C side on Page B4. So on P&C, we see an excellent level of profitability. We see a very good level of internal growth with a high-quality performance across the portfolio. Our total business volume is close to EUR 50 billion with an internal growth of 6%. And within that internal growth, retail is delivering 7%, which is very good. And what you see as well within retail is that the volume growth is at 3% in the second quarter, and it's up from the first quarter. Commercial is at 4% internal growth. And also what's very important from my perspective is that our internal growth is very well spread. So we have a high-quality portfolio, both in terms of growth and performance actually. And if you look at the internal growth, as an example, the platform business, which Oliver highlighted, at 11% of growth in direct, 10% of growth at Partners. We see Germany as well with a very nice level of growth of 6% at the half year, was 7% in the second quarter. CEE is at 7% as well or LatAm is at 13%. So big diversification of growth across the portfolio. If you also look at the pricing dynamic, overall pricing is resilient from my perspective. Retail is at 5% overall. Motor is at 7% versus -- within that one. And commercial has quite some diversity in terms of pricing dynamic. But what's very clear also is that we are extremely focused on cycle management, and we see good opportunities for growth across the portfolio, bearing in mind this technical excellence angle. Our combined ratio is at 91.4%. And you can see as well that our operating profit is at EUR 4.9 billion, which is up 9% versus last year. And this is a record level of operating profit as well on the P&C side. What we see is that also it's stemming from both commercial and retail that have a very high -- very good level of combined ratio as well, as you can see on the page. I also want to come back a bit, and Oliver has mentioned some of those items that we are extremely focused within the P&C business when it comes to delivering on our strategy. We continue to focus on revisiting our processes end-to-end, leveraging AI and starting with the customer. We are rolling out many, many tools along the value chain to be able to deliver better services and also more unique services to our customers. So for P&C, overall, we continue to deliver growth at an excellent level of profitability, and we are confident in our ability to leverage our technical strengths and our diversified portfolio to navigate the current environment and to deliver a strong performance. Let me move to Life & Health on Page B5, where overall, we see good results for this segment at the end of the first half. We see also good recovery in the second quarter of a number of negative effects we had observed in the first quarter. So the momentum is clearly good in the Life & Health business with growth of key indicators in line with our expectation across the board. So our value of new business emerged at EUR 2.4 billion which is broadly stable if you adjust for the F/X effect. And also, you may remember the fact that we did divest our JV with UniCredit last year, which is still coming in the year-on-year comparison. So also adjusted for that effect actually and also for F/X, our value of new business is up 4%. Our PVNBP is up 9% in the second quarter. So again, if you look at the half year versus the quarter, clearly, the momentum is very clear. We have as well in Life & Health, high quality and a diversified profile of the growth. Also, what we see is that we have a healthy share of protection of health and unit-linked in the underlying. I don't want to pick too many examples, but still it's tempting. So some examples in our portfolio, you will see that the Italian business has an extremely impressive growth adjusted for the portfolio cessation effect with UniCredit. So as an example, the financial adviser network had a volume growth of 16% in the second quarter. Also the U.S., as an example, we will see its sales performance up in U.S. dollar terms despite the fact that last year, we also were running a promotion in the second quarter. And there, as an example, the RILA segment is up 13% in the second quarter. The absolute level also of CSM has recovered well from the first quarter, where we had seen some market effect in line with our sensitivities. And what we see as well is that we have this improved momentum overall that is translating itself into a good development of operating profit that is up 5% F/X adjusted. So in the second quarter, we see as well that the operating profit is emerging in a very well-diversified manner across the portfolio as well. And also in the investment results on the Life & Health side, we benefit in the second quarter from our first-time dividend payment of both Viridium and Sconset, which is also supporting the development of our operating profit. So what we see overall is good first half results for the Life & Health segment. We see strength that is nicely diversified across the portfolio. And we are pleased with the improved momentum we see there, which leaves us really well on track for the full year guidance. Let's move to Asset Management on B6, where we had an excellent first half. We have a record level of net inflows of EUR 84 billion, as mentioned by Oliver. We have a double-digit revenue and profit growth. And also what's extremely strong is that both asset managers are contributing to that results. If you look at the development of the third-party assets under management, we have an annualized organic growth, which is at 8% for our business with PIMCO at 9% and AGI at 7%. This is clearly an impressive level, which is at the high end of the industry, in particular for active asset managers. We continue to add value to our customers. We have 93% of our assets under management, which are outperforming on a 3-year basis. We see as well clearly diversified regional expansion in terms of inflows, and we see as well the benefit of our product innovation. Our revenues grew by more than 16% F/X adjusted. And we see as well a very high level of resilience of our margin also linked to the very good level of product innovation we have been bringing forward. We also see the very strong focus of both asset managers when it comes to productivity, which is also showing up in the very good development of the cost/income ratio, which is allowing then a faster growth of the operating profit versus our revenue, then operating profit growing by a very impressive 19% F/X adjusted. So we are very happy with the performance in our asset management business and also the fundamental strength we see there, which is providing a lot of confidence for the future. In addition, building on those strengths, too, we have pursued 2 transactions, as already mentioned by Oliver, which are going to allow us to extract further value from our asset management business as well over time. On Page B7, which is sharing the development of our solvency ratio, I don't want to spend too much time because it's extremely clean development from my perspective. You can also see there the very consistent delivery of our operating capital generation at 11% for the half year, also fully in line with our expectations. And what I think is very important is that when you look to the future and when you look at the strength of our resilience, both in terms of solvency, but also in terms of liquidity, we are very confident in our ability to manage the newly announced M&A within our current capacity. So our resilience is very strong overall. We have a high ability to manage the volatile environment that has been mentioned by Oliver already as well. And this is for us a focus and clearly a very important aspect of the way we are operating and managing our business that we continue delivering that strength in resilience. Moving to Page B8, where I want to wrap up. First, I think it's very clear, halfway through the year, we are very confident in our ability to meet our 2026 targets. In addition to that, as we are -- as those results release actually coincide with the half of our 3-year strategic cycle, I want to take a bit of stock when it comes both to the financial KPIs, but as well the underlying strategic drivers. So on this page, on the -- sorry, left-hand side, you can see that we are very well on track, both when it comes to growth and profitability across our all segments. And that is very supportive of our ability to deliver our core EPS growth and our core ROE target as well going forward. We are also doing very well at this point in time when it comes to our operating capital generation. We are not yet at a status where we can deliver steadily the 24 to 25 percentage points of OCG that we have defined for ourselves for 2027. But this is actually fully in line with our expectation. We know that we have to work on that. We are working on it. The work is ongoing, and we are confident as well on our ability to deliver against that target. And on the right-hand side, when it comes to our strategic levers, we are -- and maybe starting with smart growth, where we are doing well. We are -- we see, in particular, as an example, on the P&C retail volume growth that we are building a momentum. We are not yet where we want to be. We have seen an improved momentum. As an example, the second quarter volume growth was at 2% -- 3%, sorry, as I have already mentioned. This is at the low end of what we want to achieve, that is between 3% and 4%. So clearly, we are making progress, but we are not yet entirely leveraging the full toolbox, and we see more opportunities to be able to deliver against our target on that side as an example. On productivity, we are clearly well on track against our target. But I think more importantly, what we see there is that we have a lot of fundamental work that is currently ongoing within the organization to transform our processes from a customer-centric perspective and also leveraging AI to advance the productivity. And this is a very critical dimension because it's critical for the next strategic cycle, obviously, but it's also quite critical in order for us to keep our product affordable and also ultimately to fuel the growth. So this is a deep focus of the organization from that angle, but also to support the first strategic lever I was mentioning, in particular, on the P&C side. And on resilience, I think I have covered already quite some dimensions, in particular, the solvency ratio side, but also sensitivities are very limited. We are also doing well when it comes to cash remittance. What is -- what we do actively as well to strengthen our resilience are 2 elements, which you see more in the underlying of the numbers as I have presented them, one which is around the active management of the cycle, and you see that in the dynamic of the growth and the way we are playing with technical excellence in our business. And the second aspect is around claims inflation uncertainty. With the overall environment also, as mentioned by Oliver, there is a need for extra caution associated with this environment, and we have built extra resilience within our reserves in the P&C business in the first half numbers in order to further strengthen our resilience. So overall, for me, this was an excellent first 6 months. We are well on track to deliver our Capital Market Day ambition. We are also well on track to continue to build resilience while sustaining profitable growth and also tapping into new technology across the value chain to prepare our future. So thank you very much. And I hand over back for questions to you, Frank.